Results 21 to 30 of about 101,312 (221)
Objectives: Triple negative breast cancer (TNBC) is a heterogenous disease and associated with unfavorable outcomes. The role of sonographic features and its association with disease outcome in TNBC is uncertain.
Haoyu Wang +5 more
doaj +1 more source
Exploring the clinicopathological parameters of HER2 low breast cancers: insights from a retrospective cohort study [PDF]
Purpose Breast cancer subtypes are delineated by human epidermal growth factor receptor 2 (HER2) expression, pivotal in treatment selection. HER2-positive tumors typically respond to targeted therapies, whereas HER2-negative tumors lack HER2 ...
Sana Ahuja +3 more
doaj +1 more source
The molecular landscape of breast mucoepidermoid carcinoma
Mucoepidermoid carcinoma (MEC) of the breast is an extremely rare salivary gland‐type tumor characterized by epidermoid, basaloid, intermediate, and/or mucinous cells arranged in solid and cystic patterns.
Konstantinos Venetis +15 more
doaj +1 more source
Immunotherapy in triple-negative breast cancer: mechanisms of resistance and emerging approaches: a narrative review [PDF]
Triple-negative breast cancer (TNBC) is characterized by less treatment responsiveness and poorer prognosis than other breast cancer subtypes. The introduction of anti-programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) immunotherapy ...
Sung Ae Koh
doaj +1 more source
High Cytoplasmic CXCR4 Expression Predicts Prolonged Survival in Triple-Negative Breast Cancer Patients Treated with Adjuvant Chemotherapy [PDF]
Background Chemokine receptor CXC chemokine receptor type 4 (CXCR4) and its ligand CXC motif chemokine 12 (CXCL12; stromal cell-derived factor-1) are implicated in tumor growth, metastasis, and tumor cell-microenvironment interaction. A number of studies
Bobae Shim +4 more
doaj +1 more source
Background Melanoma and breast cancers are two common cancers worldwide. Due to the side effects of chemotherapy drugs and the occurring resistance against them, the development of green drugs has been received more attention.
Hiva Alipanah +4 more
doaj +1 more source
Impressive effect of cisplatin monotherapy on a patient with heavily pretreated triple-negative breast cancer with poor performance [PDF]
Systemic therapy for metastatic triple-negative breast cancer (TNBC) still remains challenging because there are no targeted agents or endocrine therapies currently available.
Dong Won Baek +3 more
doaj +1 more source
BackgroundAdenoid cystic carcinoma (ACC) is a rare type of triple-negative breast cancer that has an indolent clinical behavior. Given the substantial overlapping morphological, immunohistochemical, and molecular features with other basal-like triple ...
Qian Yao +8 more
doaj +1 more source
Real-world data on adjuvant capecitabine after standard neoadjuvant chemotherapy for triple negative breast cancer [PDF]
Objective Neoadjuvant chemotherapy (NACT) has become the standard of care for patients with triple-negative breast cancer (TNBC) with tumors > 1 cm or positive axillary nodes.
Maria Fernanda Imperio Pereira +6 more
doaj +1 more source
Introduction: Microglandular adenosis (MGA) is a rare benign proliferative lesion lacking a myoepithelial cell layer; 27% of all reported cases have progressed to invasive carcinoma.
Victoria Rico +8 more
doaj +1 more source

